Health-care-associated infections: The legislative perspective and the pharmacist's role

American Journal of Health-System Pharmacy

Volumn 66, Issue 5, 2009, Pages 488-494

  Kuper, Kristi M ^a,c   Septimus, Edward J ^b  

^a Infectious Diseases Consultants   (United States)

^b HCA Healthcare System   (Netherlands)

^c Department of Clinical Affairs ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOODSTREAM INFECTION; CATHETER INFECTION; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; LAW; LENGTH OF STAY; MEDICAID; MEDICARE; NOTE; PHARMACIST; PRIORITY JOURNAL; REIMBURSEMENT; SURGICAL INFECTION; URINARY TRACT INFECTION; VENTILATOR ASSOCIATED PNEUMONIA; ARTICLE; CROSS INFECTION; EVIDENCE BASED MEDICINE; HEALTH CARE POLICY; HEALTH CARE QUALITY; HOSPITAL PHARMACY; INFECTION CONTROL; LEGAL ASPECT; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; UNITED STATES;

CROSS INFECTION; EVIDENCE-BASED MEDICINE; HEALTH CARE COSTS; HEALTH POLICY; HUMANS; INFECTION CONTROL; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 63149126797     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp080266     Document Type: Note

References (51)

1. Klevens RM, Edwards JR, Richards CL et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007; 122:160-6.
2. Roberts RR, Scott RD, Cordell R et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis. 2003; 36:1424-32.
3. Perencevich EN, Stone PW, Wright SB et al. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007; 28:1121-33.
4. Kilgore ML, Ghosh K, Beavers CM et al. The costs of nosocomial infections. Med Care. 2008; 46:101-4.
5. Murphy D, Whiting J. Association for Professionals in Infection Control and Epidemiology, Inc. Dispelling the myths: the true cost of healthcare-associated infections. www.apic.org/AM/Template.cfm?Section= Search&csection=News-Release&ctemplate=/CM/ContentDisplay. cfm©cContentfileID=7764 (accessed 2008 Dec 9).
6. Institute for Healthcare Improvement. Implement the ventilator bundle: improvement reports. www.ihi.org/IHI/Topics/CriticalCare/IntensiveCare/Changes/ Implementthe Ventilator Bundle.htm (accessed 2008 Apr 21).
7. Costello JM, Morrow DF, Graham DA et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008; 121:915-23.
8. Haley RW, Culver DH, White JW et al. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol. 1985; 121:159-67.
9. Weinstein RA. Nosocomial infection update. Emerging Infect Dis. 1998; 4:416-20.
10. Horan TC, Gaynes R. Surveillance of nosocomial infections. In: Mayhall CG, ed. Hospital epidemiology and infection control. Philadelphia: Lippincott Williams & Wilkins; 2004:1659-702.
11. McKibben L, Horan T, Tokars JI et al. Guidance on public reporting of healthcare-associated infections: recommendations of the Healthcare Infection Control Practices Advisory Committee. Am J Infect Control. 2005; 33:217-26.
12. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171:388-416.
13. O'Brien JA, Lahue BJ, Caro JJ et al. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect Control Hosp Epidemiol. 2007; 28:1219-27.
14. Siegel JD, Rhinehart E, Jackson M et al. Management of multidrug-resistant organisms in healthcare settings, 2006. www.cdc.gov/ncidod/ dhqp/pdf/ar/mdroGuideline2006.pdf (accessed 2008 May 1).
15. Klevens RM, Morrison MA, Nadle J et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007; 298:1763-71.
16. Tambyah PA, Maki DG. Catheter-associated urinary tract infection is rarely symptomatic: a prospective study of 1,497 catheterized patients. Arch Intern Med. 2000; 160:678-82.
17. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med. 2002; 113(suppl 1A):5S-13S.
18. Centers for Disease Control and Prevention. Guideline for prevention of catheter-associated urinary tract infections. www.cdc.gov/ncidod/dhqp/gl- catheter-assoc.html (accessed 2008 Apr 23).
19. Stephan F, Sax H, Wachsmuth M et al. Reduction of urinary tract infection and antibiotic use after surgery: a controlled, prospective, before-after intervention study. Clin Infect Dis. 2006; 42:1544-51.
20. Saint S, Kowalski CP, Kaufman SR et al. Preventing hospital-acquired urinary tract infection in the United States: a national study. Clin Infect Dis. 2008; 46:243-50.
21. Defrances CJ, Hall MJ. 2005 national hospital discharge survey. Adv Data. 2007; 12(385):l-20.
22. Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006; 43:322-30.
23. Dellinger EP, Hausmann SM, Bratzler DW et al. Hospitals collaborate to decrease surgical site infections. Am J Surg. 2005; 190:9-15.
24. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm. 1999; 56:1839-88.
25. Cunnion KM, Weber DJ, Broadhead WE et al. Risk factors for nosocomial pneumonia: comparing adult critical-care populations. Am J Respir Crit Care Med. 1996; 153:158-62.
26. Rello J, Ollendorf DA, Oster G et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002; 122:2115-21.
27. Centers for Disease Control and the Healthcare Infection Control PracticesAdvisory Committee. Guidelines for pre-ventinghealthcare- associatedpneumonia, 2003. www.cdc.gov/ncidod/dhqp/pdf/guidelines/CDCpneumo- guidelines.pdf (accessed 2008 Apr 22).
28. Centers for Medicare and Medicaid Services, HHS. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2008 rates. Fed Regist. 2007; 72:47129-8175.
29. Zack JE, Garrison T, Trovillion E et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med. 2002; 30:2407-12.
30. Resar R, Pronovost P, Haraden C et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf. 2005; 31:243-8.
31. Marschall J, Leone C, Jones M et al. Catheter-associated bloodstream infections in general medical patients outside the intensive care unit: a surveillance study. Infect Control Hosp Epidemiol. 2007; 28:905-9.
32. Blot SI, Depuydt P, Annemans L et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005; 41:1591-8.
33. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections.Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002; 51:1-29.
34. Shannon RP, Patel B, Cummins D et al. Economics of central line-associated bloodstream infections. Am J Med Qual. 2006; 21(suppl6):7S-16S.
35. Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006; 355:2725-32.
36. Congressional Budget Office. CBO testimony. Statement of Peter R. Orszag, Director before the Committee on the Budget, U.S. House of Representatives. www.cbo.gov/ftpdocs/88xx/doc8876/12-05-HBCMacroTestimony.pdf (accessed 2008 Apr 13).
37. Centers for Medicare and Medicaid Services. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2009 rates. Fed Regist. 2008; 73:48433-9084.
38. Centers for Medicare and Medicaid Services. CMS manual system. www.cms.hhs.gov/transmittals/downloads/R1240CP.pdf (accessed 2008 Apr 19).
39. Infectious Diseases Society of America. Strategies to address antimicrobial resistance. www.idsociety.org/STAARAct.htm (accessed 2008 Apr 12).
40. APIC. Legislation in process, www. apic.org/scriptcontent/custom/ dyncontent/legislation/index.cfm?section=government-advocacy (accessed 2008 Apr 15).
41. Pennsylvania Health Care Cost Containment Council. Research brief: hospital-acquired infections in Pennsylvania, 2004. www.phc4.org/reports/ research briefs/071205/docs/researchbrief2005 report-hospacqinfections.pdf (accessed 2008 Apr 18).
42. New Jersey State Legislature. Public law 2007, chapter 120. www.njleg.state.nj.us/2006/Bills/PL07/120-.pdf (accessed 2008 Apr 18).
43. Illinois General Assembly. Public act 095-0312. www.ilga.gov/legislation/ publicacts/95/PDF/095-03 12.pdf (accessed 2008 Apr 19).
44. American Society of Health-System Pharmacists. A crosswalk linking national quality indicators with national organizations, legislation, and clinical practice guidelines supporting the use of the indicators, www.ashp.org/s-ashp/docs/files/QII-Crosswalk062907.pdf (accessed 2008 Aug 25).
45. The Joint Commission. 2009 National Patient Safety Goals. Hospital program. www.jointcommission.org/PatientSafety/NationalPatientSafetyGoals/09- hap-npsgs.htm (accessed 2008 Aug 25).
46. Hermsen ED, Shull SS, Puumala S et al. Improvement in prescribing habits and economic outcomes associated with the introduction of a standardized approach for surgical antimicrobial prophylaxis. Infect Control Hosp Epidemiol. 2008; 29:457-61.
47. McCahill LE, Ahern JW, Gruppi L et al. Enhancing compliance with Medicare guidelines for surgical infection prevention. Arch Surg. 2007; 142:355-61.
48. Sokos D. Pharmacists' role in increasing pneumococcal and influenza vaccination. Am J Health-Syst Pharm. 2005; 62:367-77.
49. Yokoe DS, Mermel LA, Anderson DJ et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008; 29(suppl 1):S12-S21.
50. Dellit TH, Owens RC, McGowan JE et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
51. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000; 31(suppl4):S131-8.